Stay updated on Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:48:05.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.4.2' was added, and the funding-status notice and 'Revision: v3.4.1' were removed. These are administrative changes that do not alter study information or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:41:33.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide funding status notice and updated references to the NIH Clinical Center's operating status, including links to opm.gov. Updated the revision tag from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T08:00:19.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Glossary is now shown on the page, and there are minor capitalization updates to QC labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with a new revision note 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:35:49.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 has been added and Revision: v3.3.3 has been removed.
    Difference
    0.0%
    Check dated 2026-01-14T02:46:35.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Locations section added with California as a location; California Locations subsection removed. HHS Vulnerability Disclosure link removed; page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T16:57:00.000Z thumbnail image

Stay in the know with updates to Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.